Idiopathic Pulmonary Fibrosis Clinical Trials

A listing of Idiopathic Pulmonary Fibrosis medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35294

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Birmingham Alabama 35233

A clinical research study of GBT440 and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Birmingham Alabama 35233

A clinical trial seeking patients for a research study for the treatment of Idiopathic Pulmonary Fibrosis

UPDATED

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study of Nintedanib, Placebo and Sildenafil to evaluate Idiopathic Pulmonary Fibrosis

UPDATED

Jasper Alabama 35501

Patients are needed to participate in a clinical research study of nintedanib and placebo to evaluate Idiopathic Pulmonary Fibrosis

Arizona

Phoenix Arizona 85013

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Phoenix Arizona 85006

Patients are needed to participate in a clinical research study evaluating KD025 and Standard of Care for the treatment of Idiopathic Pulmonary Fibrosis

Tucson Arizona 85724

Patients are needed to participate in a clinical research study evaluating KD025 and Standard of Care for the treatment of Idiopathic Pulmonary Fibrosis

California

La Jolla California 92037

A clinical research study of Pirfenidone and Vismodegib for the treatment of Idiopathic Pulmonary Fibrosis

Los Angeles California 90024

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Los Angeles California 90095-1690

A clinical trial seeking patients for a research study for the treatment of Pulmonary Arterial Hypertension, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease or Pulmonary Hypertension

Los Angeles California 90095

Patients are needed to participate in a clinical research study evaluating treprostinil for the treatment of Pulmonary Arterial Hypertension, Interstitial Lung Disease or Idiopathic Pulmonary Fibrosis

Los Angeles California 90095-1690

Patients are needed to participate in a clinical research study of bosentan and No specific intervention to evaluate Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

View More ▼

Los Angeles California 90095-1690

Patients are needed to participate in a clinical research study of bosentan and No specific intervention to evaluate Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Sacramento California 95817

Patients are needed to participate in a clinical research study evaluating KD025 and Standard of Care for the treatment of Idiopathic Pulmonary Fibrosis

Stanford California 94305

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Colorado

Denver Colorado 80206

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Denver Colorado 80206

A clinical research study of GBT440 and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Denver Colorado 80206

A clinical trial seeking patients for a research study for the treatment of Idiopathic Pulmonary Fibrosis

Connecticut

UPDATED

Danbury Connecticut 06810

Patients are needed to participate in a clinical research study of nintedanib and placebo to evaluate Idiopathic Pulmonary Fibrosis

New Haven Connecticut 06520

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Stamford Connecticut 06902

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

UPDATED

Stamford Connecticut 06902-3633

Patients are needed to participate in a clinical research study of Nintedanib, Placebo and Sildenafil to evaluate Idiopathic Pulmonary Fibrosis

Florida

Pulmonary Disease Specialists, PA, d/b/a PDS Research
Kissimmee Florida

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

University of Miami Pulmonary Clinics
Miami Florida 33136

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

View More ▼

Clearwater Florida 33765

Patients are needed to participate in a clinical research study evaluating KD025 and Standard of Care for the treatment of Idiopathic Pulmonary Fibrosis

UPDATED

Clearwater Florida 33765

Patients are needed to participate in a clinical research study of nintedanib and placebo to evaluate Idiopathic Pulmonary Fibrosis

UPDATED

Jacksonville Florida 32209

Patients are needed to participate in a clinical research study of nintedanib and placebo to evaluate Idiopathic Pulmonary Fibrosis

UPDATED

Jacksonville Florida 32209

Patients are needed to participate in a clinical research study of Nintedanib, Placebo and Sildenafil to evaluate Idiopathic Pulmonary Fibrosis

Kissimmee Florida 34741

Patients are needed to participate in a clinical research study evaluating KD025 and Standard of Care for the treatment of Idiopathic Pulmonary Fibrosis

Orlando Florida 32803

Patients are needed to participate in a clinical research study evaluating KD025 and Standard of Care for the treatment of Idiopathic Pulmonary Fibrosis

Georgia

Emory University
Atlanta Georgia 30322

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

View More ▼

Austell Georgia 30106

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Illinois

Chicago Illinois 60637

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

UPDATED

Chicago Illinois 60637

Patients are needed to participate in a clinical research study of Nintedanib, Placebo and Sildenafil to evaluate Idiopathic Pulmonary Fibrosis

Indiana

Muncie Indiana 47303

A clinical research study of Pirfenidone and Vismodegib for the treatment of Idiopathic Pulmonary Fibrosis

Kansas

University of Kansas
Kansas City Kansas

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

View More ▼

Kansas City Kansas 66160

A clinical research study of GBT440 and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

UPDATED

Kansas City Kansas 66160

Patients are needed to participate in a clinical research study of Nintedanib, Placebo and Sildenafil to evaluate Idiopathic Pulmonary Fibrosis

Kentucky

NEW

Baptist Health Clinical Research Center & Lexington Cardiac Research Foundation
Lexington Kentucky 40353

Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry

View More ▼

Lexington Kentucky 40503

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Louisville Kentucky 40202

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Louisiana

New Orleans Louisiana 70112

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

New Orleans Louisiana 70122

A clinical research study of GBT440 and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

New Orleans Louisiana 70122

A clinical trial seeking patients for a research study for the treatment of Idiopathic Pulmonary Fibrosis

Massachusetts

Brigham and Women's Hospital
Boston Massachusetts 02116

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Massachusetts General Hospital
Boston Massachusetts 02114

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

View More ▼

Burlington Massachusetts 01803

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Michigan

Ann Arbor Michigan 48109

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

UPDATED

Ann Arbor Michigan 48109

Patients are needed to participate in a clinical research study of Nintedanib, Placebo and Sildenafil to evaluate Idiopathic Pulmonary Fibrosis